Recreo Pharmaceuticals
Recreo Pharmaceuticals: Innovating antibody therapeutics to combat antibiotic resistance.
Founded
2013Recreo Pharmaceuticals: Innovating antibody therapeutics to combat antibiotic resistance.
Recreo Pharmaceuticals is a biotechnology company dedicated to developing innovative antibody therapeutics to combat antibiotic resistance. The company focuses on creating structurally unique resistance-modifying agents for infectious diseases, enabling researchers to effectively control bacterial antibiotic resistance. With a commitment to innovation, Recreo Pharmaceuticals leverages the latest trends and technologies in antibiotics drug development and testing to address critical healthcare challenges.
Recreo Pharmaceuticals has made significant strides in the field of antibiotic resistance, contributing to the advancement of medical science and public health. The company's team of experienced professionals continuously updates their knowledge and skills to stay at the forefront of antibiotics technology. Through their pioneering work, Recreo Pharmaceuticals aims to provide effective solutions that enhance the efficacy of existing antibiotics and improve patient outcomes in the fight against resistant bacterial infections.
Companies similar to Recreo Pharmaceuticals include Recida Therapeutics, Synereca Pharmaceuticals, X-Biotix Therapeutics and Nexcida Therapeutics.
Recreo Pharmaceuticals was founded in 2013.
Recreo Pharmaceuticals' headquarters is located in Superior, CO, US.
Recreo Pharmaceuticals' most recent funding round was for $3M (USD) in November 2017.
As of Nov 6, 2017, Recreo Pharmaceuticals has disclosed funding of $3M (USD). Undisclosed round amounts are excluded.
Recreo Pharmaceuticals has 5 employees as of Feb 5, 2024.
Nexcida Therapeutics
